Sector valuations GC Genome Corporation
Stocks
A340450
KR7340450006
Healthcare Facilities & Services
|
End-of-day quote
Korea S.E.
23/09/2026
|
5-day change | 1st Jan Change | ||
| 8,180.00 KRW | +12.21% |
|
+21.55% | +19.94% |
| 12-09 | GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy | CI |
| 12/06/25 | GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | - | 3.44x | - | 33.52x | - | 142M | |
| -286.88x | 29.02x | 27.64x | 18.99x | -341.11x | -249.14x | -.--% | 56.33B | |
| 21.82x | 2.75x | 0.66x | 2.02x | 11.43x | 13.66x | 0.96% | 24.65B | |
| 15.5x | 1.07x | 1.04x | 1.24x | 7.02x | 12.88x | 5.65% | 6.62B | |
| 1045.86x | - | -8.17x | - | - | - | - | 5.76B | |
| 52x | 11.26x | 2.39x | 9.6x | 33.03x | 41x | 0.96% | 3.36B | |
| -25.39x | - | -0.07x | - | - | - | - | 2.54B | |
| -61.97x | - | 0.96x | - | - | - | -.--% | 2.36B | |
| 15.91x | 2.25x | 0.68x | 1.66x | 6.48x | 10.66x | 4.87% | 2.32B | |
| 32.85x | 1.9x | -0.1x | 1.73x | 12.93x | 22.04x | 1.37% | 1.98B | |
| 33.24x | 1.96x | 0.04x | 1.22x | 9.73x | 14.15x | 0.8% | 1.92B | |
| 71.94x | 13.9x | 2.4x | 15.93x | 37.81x | 50.09x | 0.11% | 1.69B | |
| -7.6x | 0.74x | 0.3x | 1.48x | - | -5.38x | - | 1.27B | |
| 41.33x | 1.48x | -1.48x | 0.87x | 7.39x | 25.16x | 3.45% | 1.26B | |
| 37.65x | 2.83x | 1.47x | - | - | - | 0.26% | 1.17B | |
| 43.71x | 14.37x | 1.55x | - | - | - | 1.92% | 953M | |
| 18.26x | 1.05x | -14.35x | - | - | - | 3.41% | 869M | |
| Average | 65.51x | 6.51x | 0.93x | 5.29x | -23.92x | -2.85x | 1.83% | 6.78B | |
| Weighted average by Cap. | -79.09x | 17.29x | 13.37x | 11.82x | -186.21x | -130.65x | 0.85% |
- Stock Market
- Stocks
- A340450 Stock
- Sector GC Genome Corporation
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
